Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Feasibility and acceptability of remote symptom monitoring (RSM) in older adults during treatment for metastatic prostate cancer.
Feng G, Parthipan M, Breunis H, Puts M, Emmenegger U, Timilshina N, Hansen AR, Finelli A, Krzyzanowska MK, Matthew A, Clarke H, Mina DS, Soto-Perez-de-Celis E, Tomlinson G, Alibhai SMH. Feng G, et al. Among authors: emmenegger u. J Geriatr Oncol. 2023 Apr;14(3):101469. doi: 10.1016/j.jgo.2023.101469. Epub 2023 Mar 12. J Geriatr Oncol. 2023. PMID: 36917921
Daily physical activity monitoring in older adults with metastatic prostate cancer on active treatment: Feasibility and associations with toxicity.
Feng G, Parthipan M, Breunis H, Timilshina N, Soto-Perez-de-Celis E, Mina DS, Emmenegger U, Finelli A, Krzyzanowska MK, Clarke H, Puts M, Alibhai SMH. Feng G, et al. Among authors: emmenegger u. J Geriatr Oncol. 2023 Sep;14(7):101576. doi: 10.1016/j.jgo.2023.101576. Epub 2023 Jul 6. J Geriatr Oncol. 2023. PMID: 37421787
Understanding the incidence, duration, and severity of symptoms through daily symptom monitoring among frail and non-frail older patients receiving metastatic prostate cancer treatments.
Parthipan M, Feng G, Breunis H, Timilshina N, Emmenegger U, Hansen A, Tomlinson G, Matthew A, Clarke H, Santa Mina D, Soto-Perez-de-Celis E, Puts M, Alibhai SMH. Parthipan M, et al. Among authors: emmenegger u. J Geriatr Oncol. 2024 Apr;15(3):101720. doi: 10.1016/j.jgo.2024.101720. Epub 2024 Feb 13. J Geriatr Oncol. 2024. PMID: 38350343 Free article.
Symptom experiences of older adults during treatment for metastatic prostate cancer: A qualitative investigation.
Parthipan M, Feng G, Toledano N, Donison V, Breunis H, Sudharshan A, Emmenegger U, Finelli A, Warde P, Soto-Perez-de-Celis E, Krzyzanowska M, Matthew A, Clarke H, Mina DS, Alibhai SMH, Puts M. Parthipan M, et al. Among authors: emmenegger u. J Geriatr Oncol. 2023 Jan;14(1):101397. doi: 10.1016/j.jgo.2022.10.012. Epub 2022 Oct 28. J Geriatr Oncol. 2023. PMID: 36988104
Implementing geriatric assessment and management for older Canadians with cancer: Adherence to and satisfaction with the intervention, results of the 5C study.
Puts M, Waked JAA, Strohschein F, Breunis H, Alqurini N, Berger A, Romanovsky L, Monette J, Mehta R, Li A, Wan-Chow-Wah D, Koneru R, Szumacher E, Mariano C, Hsu T, Brennenstuhl S, Amir E, Krzyzanowska MK, Jang R, Pitters E, Emmenegger U, Menjak IB, Bergman S, Lemonde M, Beland F, Alibhai SMH. Puts M, et al. Among authors: emmenegger u. J Geriatr Oncol. 2023 Sep;14(7):101586. doi: 10.1016/j.jgo.2023.101586. Epub 2023 Jul 15. J Geriatr Oncol. 2023. PMID: 37459767 Free article.
TOward a comPrehensive supportive Care intervention for Older men with metastatic Prostate cancer (TOPCOP3): A pilot randomized controlled trial and process evaluation.
Alibhai SMH, Puts M, Jin R, Godhwani K, Antonio M, Abdallah S, Feng G, Krzyzanowska MK, Soto-Perez-de-Celis E, Papadopoulos E, Mach C, Nasiri F, Sridhar SS, Glicksman R, Moody L, Bender J, Clarke H, Matthew A, McIntosh D, Klass W, Emmenegger U. Alibhai SMH, et al. Among authors: emmenegger u. J Geriatr Oncol. 2024 Jul;15(6):101750. doi: 10.1016/j.jgo.2024.101750. Epub 2024 Mar 23. J Geriatr Oncol. 2024. PMID: 38521641 Free article.
Pembrolizumab and Enzalutamide in Patients with Abiraterone Acetate-Pretreated Metastatic Castration-Resistant Prostate Cancer: Cohort C of the Phase 1b/2 KEYNOTE-365 Study.
Yu EY, Berry WR, Gurney H, Retz M, Conter HJ, Laguerre B, Fong PCC, Ferrario C, Todenhöfer T, Gravis G, Piulats JM, Emmenegger U, Shore ND, Romano E, Mourey L, Li XT, Poehlein CH, Schloss C, Appleman LJ, de Bono JS. Yu EY, et al. Among authors: emmenegger u. Eur Urol Oncol. 2024 Jun;7(3):509-518. doi: 10.1016/j.euo.2023.10.008. Epub 2023 Nov 7. Eur Urol Oncol. 2024. PMID: 37940446 Free article. Clinical Trial.
Pembrolizumab plus Abiraterone Acetate and Prednisone in Patients with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Results from KEYNOTE-365 Cohort D.
Yu EY, Ferrario C, Linch MD, Stoeckle M, Laguerre B, Arranz JA, Todenhöfer T, Fong PC, Piulats JM, Berry W, Emmenegger U, Mourey L, Joshua AM, Mar N, Appleman LJ, Conter HJ, Gravis G, Li XT, Schloss C, Poehlein C, de Bono JS. Yu EY, et al. Among authors: emmenegger u. Eur Urol Oncol. 2024 Jun 25:S2588-9311(24)00145-7. doi: 10.1016/j.euo.2024.05.013. Online ahead of print. Eur Urol Oncol. 2024. PMID: 38926066 Free article.
128 results